Exploring brain connectivity changes in major depressive disorder using functional-structural data fusion: A CAN-BIND-1 study
- PMID: 34296501
- PMCID: PMC8449113
- DOI: 10.1002/hbm.25590
Exploring brain connectivity changes in major depressive disorder using functional-structural data fusion: A CAN-BIND-1 study
Abstract
There is a growing interest in examining the wealth of data generated by fusing functional and structural imaging information sources. These approaches may have clinical utility in identifying disruptions in the brain networks that underlie major depressive disorder (MDD). We combined an existing software toolbox with a mathematically dense statistical method to produce a novel processing pipeline for the fast and easy implementation of data fusion analysis (FATCAT-awFC). The novel FATCAT-awFC pipeline was then utilized to identify connectivity (conventional functional, conventional structural and anatomically weighted functional connectivy) changes in MDD patients compared to healthy comparison participants (HC). Data were acquired from the Canadian Biomarker Integration Network for Depression (CAN-BIND-1) study. Large-scale resting-state networks were assessed. We found statistically significant anatomically-weighted functional connectivity (awFC) group differences in the default mode network and the ventral attention network, with a modest effect size (d < 0.4). Functional and structural connectivity seemed to overlap in significance between one region-pair within the default mode network. By combining structural and functional data, awFC served to heighten or reduce the magnitude of connectivity differences in various regions distinguishing MDD from HC. This method can help us more fully understand the interconnected nature of structural and functional connectivity as it relates to depression.
Keywords: data fusion; functional connectivity; major depressive disorder; neuroimaging; resting brain networks; structural connectivity; toolbox.
© 2021 The Authors. Human Brain Mapping published by Wiley Periodicals LLC.
Conflict of interest statement
Dr. Milev has received consulting and speaking honoraria from Allergan, Janssen, KYE, Lundbeck, Otsuka, Pfizer and Sunovion, and research grants from CAN‐BIND, CIHR, Janssen, Lallemand, Lundbeck, Nubiyota, OBI, OMHF and Pfizer. Dr. Frey has received a research grant from Pfizer. Dr. Strother receives funding from the OBI and CIHR (MOP137097) for neuroimaging analysis in CAN‐BIND and he is the Chief Scientific Officer of ADMdx, Inc., a neuroimaging consulting company. Dr. MacQueen has had consultant payments or honoraria from: Allergen, Pfizer, Lundbeck, Janssen, Johnson & Johnson. Dr. Kennedy has received research funding or honoraria from the following sources: Abbott, Alkermes, Allergan, BMS, Brain Canada, Canadian Institutes for Health Research (CIHR), Janssen, Lundbeck, Lundbeck Institute, Ontario Brain Institute, Ontario Research Fund (ORF), Otsuka, Pfizer, Servier, Sunovion and Xian‐Janssen. Dr. Kennedy holds stock in Field Trip Health. Dr. Lam has received honoraria for ad hoc speaking or advising/consulting, or received research funds, from: Allergan, Asia‐Pacific Economic Cooperation, BC Leading Edge Foundation, Canadian Institutes of Health Research, Canadian Network for Mood and Anxiety Treatments, Canadian Psychiatric Association, Hansoh, Healthy Minds Canada, Janssen, Lundbeck, Lundbeck Institute, MITACS, Movember Foundation, Ontario Brain Institute, Otsuka, Pfizer, St. Jude Medical, University Health Network Foundation, and VGH‐UBCH Foundation. All other authors report no biomedical financial interests or potential conflicts of interest.
Figures
References
-
- American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
-
- American Psychiatric Association (2013). Diagnostic and Statistical Manual of Mental Disorders (vol. 5, pp. 1414). Washington, DC: American Psychiatric Association.
-
- Biswal, B. B., Van Kylen, J., & Hyde, J. S. (1997). Simultaneous assessment of flow and BOLD signals in resting‐state functional connectivity maps. NMR in Biomedicine, 10(4–5), 165–170. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
